Skip to main content
TipRanks
Go Ultimate75% OFF

David Loury Insider Profile

4 Followers

David Loury, former Executive VP, Toxicology at Pharmacyclics, holds 1.63K shares in Pharmacyclics (Ticker: PCYC).

David Loury's Trading History

PCYC
Pharmacyclics
Nov 05, 2013―Uninformative Buy12.02K―
PCYC
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Nov 05, 2013Uninformative Buy$12.02K1,139$10.55―
May 01, 2013Uninformative Buy$1.73K164$10.55―
Feb 05, 2013Uninformative Sell$1.41M20,000$70.57―
Jan 09, 2013Informative Sell$698.21K10,531$66.300.00%
Jan 09, 2013Informative Buy$43.81K10,531$4.16+94.50%

You May Also Like

David Loury insider profile FAQ

What is the percentage of profitable transactions made by David Loury?
The percentage of profitable transactions made by David Loury is 25%.
What is the average return per transaction made by David Loury?
The average return per transaction made by David Loury is 20.00%.
What stocks does David Loury hold?
David Loury holds: PCYC stocks.
What was David Loury’s latest transaction?
David Loury’s latest transaction was an Uninformative Buy of $12.02K.
What was David Loury's most profitable transaction?
David Loury’s most profitable transaction was an Informative Buy of PCYC stock on January 9, 2013. The return on the trade was 94.50%.
What is David Loury's role in Pharmacyclics?
David Loury's role in Pharmacyclics is Executive VP, Toxicology.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.